Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pfizer : United States Donates 1.6 Million More COVID-19 Pfizer Vaccines to Egypt This is part of more than 8 million Pfizer vaccine doses the United States is sending to Egypt

10/17/2021 | 04:24am EST

U.S. Ambassador Jonathan R. Cohen welcomed the arrival of a second shipment of Pfizer’s COVID-19 vaccines to Cairo. The shipment ofan additional1.6 million Pfizer doses is part of a 500-million-dose donation from the United States to the countries of the African Union through COVAX, and will help protect Egyptians from COVID-19 and prevent the spread of the virus’s dangerous new strains.

At the arrival ceremony, also attended by Pfizer, WHO, and UNICEF partners, Ambassador Cohen noted, "I am so pleased to celebrate the arrival of this vaccine shipment, the second direct donation of 1.6 million doses of Pfizer from the people of the United States to the people of Egypt.This is part of more than 8 million Pfizer vaccine doses the United States is sending to Egypt.Today’s vaccine donation underscores our continuing commitment to support Egypt through this global health crisis."

Dr. Naeema AlGasseer, WHO representative in Egypt stated,"the arrival of the second shipment of Pfizer’s COVID-19 vaccines to Egypt from United States is yet another act of solidarity and cooperation towards reaching the goal of 40% vaccination coverage and helping vaccinate the most at — risk population especially the front-line health workers. WHO is extremely thankful to United States’ generosity that will contribute to tackling vaccine inequity." 

"Reliable cold chain is essential to keeping vaccines effective. The procurement and delivery of Pfizer vaccines, prompted many countries including Egypt to upgrade their cold chain equipment to keep up with the new technology requiring ultra-cold conditions. So far, we have successfully delivered and installed 20 ultra-low temperature freezers in 6 governorates across the country. At UNICEF, we are pleased to be supporting Egypt in this upgrade and we would like to extend our thanks to the COVAX donors who make this possible, so that more vaccines can be delivered while preserving their potency to protect the people in Egypt and to keep them safe from COVID-19", said UNICEF Representative in Egypt, Jeremy Hopkins.

U.S. cooperation with Egypt in fighting the pandemic is wide-ranging. At the outset of the pandemic, Egypt sent medical supplies to the United States. The U.S. government, through USAID, has provided more than $55 million to support Egypt’s Coronavirus response, already reaching nearly 18 million people with needed health and economic support. USAID programs train health care workers, improve tracking of and response to the pandemic, provide food assistance to families affected by the pandemic, and support small businesses. Just this week, the U.S. Government announced an additional $5 million in assistance to Egypt to support health workers administering vaccines and strengthen the supply chain for vaccines. This support builds on more than $1 billion in the United States has invested over the past 40 years to improve the health of all Egyptians.

ThesePfizer doses will be swiftly dispatched to Ministry of Health and Population facilities in Cairo, Port Said,Daqahlya,Behaira, Luxor, and Assiut, and stored in UNICEF-funded ultra-cold storage equipment used exclusively for the Pfizer vaccine.

The U.S.-Egypt partnership is saving lives and helping Egypt move towards economic recovery. As President Biden said, "From the beginning of my presidency, we have been clear-eyed that we need to attack this virus globally as well. This is about our responsibility–our humanitarian obligation to save as many lives as we can–and our responsibility to our values. We’re going to help lead the world out of this pandemic, working alongside our global partners." Worldwide, the United States has delivered more than 180 million COVID-19 vaccines and hundreds of millions more are on their way.


Distributed by APO Group on behalf of U.S. Embassy - Cairo, Egypt.

© African Press Organization, source Press Releases

All news about PFIZER, INC.
11/27How worried should we be about the Omicron variant?
RE
11/27PARENTING IN A PANDEMIC : To Vaccinate Or Not To Vaccinate?
AQ
11/26ADRs Close Lower; BioNTech Rises, Carnival Drops
DJ
11/26US Stocks, Treasury Yields Sink With Crude Oil as Concern Mounts Over New COVID-19 Stra..
MT
11/26CLOSE UPDATE : US Stocks, Treasury Yields Sink With Crude Oil as Concern Mounts Over New C..
MT
11/26FTSE 100 Closes Friday Down as Latest Coronavirus Variant Sparks Sell-off
DJ
11/26Covid-19 Vaccine Maker Stocks Higher Amid Variant Concerns
DJ
11/26New purchase in the MarketScreener USA Portfolio
11/26FDA Places Clinical Hold on Phase 3 Study for Ocugen COVID-19 Vaccine Covaxin
MT
11/26Pfizer Up Over 6%, on Track for Record High Close -- Data Talk
DJ
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 81 529 M - -
Net income 2021 21 354 M - -
Net Debt 2021 27 827 M - -
P/E ratio 2021 13,9x
Yield 2021 2,92%
Capitalization 303 B 303 B -
EV / Sales 2021 4,06x
EV / Sales 2022 3,97x
Nbr of Employees 78 500
Free-Float 59,3%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 54,00 $
Average target price 48,53 $
Spread / Average Target -10,1%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Susan Silbermann President & General Manager-Pfizer Vaccines
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.46.70%303 095
JOHNSON & JOHNSON1.82%419 109
ROCHE HOLDING AG16.05%336 162
NOVO NORDISK A/S67.00%247 254
ELI LILLY AND COMPANY54.21%236 049
ABBVIE INC.8.74%205 976